Outset Medical (OM)
(Delayed Data from NSDQ)
$0.71 USD
-0.01 (-0.95%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $0.71 0.00 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for Outset Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 203 | 288 | 339 | 315 | 70 |
Receivables | 33 | 28 | 26 | 6 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 49 | 51 | 39 | 18 | 5 |
Other Current Assets | 6 | 7 | 6 | 6 | 1 |
Total Current Assets | 291 | 374 | 410 | 346 | 80 |
Net Property & Equipment | 13 | 16 | 13 | 15 | 8 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 4 | 4 | 33 | 35 | 1 |
Total Assets | 314 | 400 | 463 | 404 | 88 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 6 | 1 | 2 | 5 | 5 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 8 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 36 | 41 | 42 | 28 | 12 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12 | 9 | 6 | 3 | 1 |
Total Current Liabilities | 55 | 52 | 52 | 37 | 25 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 130 | 96 | 30 | 30 | 22 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 0 | 1 | 0 | 5 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 191 | 154 | 89 | 75 | 51 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 409 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,085 | 1,035 | 1,000 | 823 | 0 |
Retained Earnings | -962 | -789 | -626 | -494 | -373 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 123 | 246 | 374 | 329 | 37 |
Total Liabilities & Shareholder's Equity | 314 | 400 | 463 | 404 | 88 |
Total Common Equity | 123 | 246 | 374 | 329 | -372 |
Shares Outstanding | 50.20 | 48.30 | 47.00 | 42.70 | NA |
Book Value Per Share | 2.45 | 5.09 | 7.96 | 7.70 | 0.00 |
Fiscal Year End for Outset Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 195 | 227 | 203 | 194 | 223 |
Receivables | 34 | 36 | 33 | 35 | 37 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 62 | 56 | 49 | 48 | 45 |
Other Current Assets | 5 | 6 | 6 | 6 | 5 |
Total Current Assets | 295 | 325 | 291 | 284 | 309 |
Net Property & Equipment | 11 | 12 | 13 | 14 | 15 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 4 | 4 | 4 | 4 | 4 |
Total Assets | 315 | 346 | 314 | 308 | 334 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 7 | 6 | 3 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 23 | 29 | 36 | 38 | 34 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 13 | 13 | 12 | 11 | 11 |
Total Current Liabilities | 43 | 51 | 55 | 53 | 49 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 197 | 197 | 130 | 97 | 97 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 1 | 1 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 246 | 253 | 191 | 155 | 151 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,105 | 1,095 | 1,085 | 1,075 | 1,060 |
Retained Earnings | -1,036 | -1,002 | -962 | -923 | -877 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 69 | 93 | 123 | 152 | 183 |
Total Liabilities & Shareholder's Equity | 315 | 346 | 314 | 308 | 334 |
Total Common Equity | 69 | 93 | 123 | 152 | 183 |
Shares Outstanding | 51.70 | 51.70 | 50.20 | 49.70 | 49.70 |
Book Value Per Share | 1.33 | 1.80 | 2.45 | 3.06 | 3.68 |